Indian Ministry Wants to Cancel Patent on Roche Cancer Drug
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
If Roche execs thought they escaped having a dogfight in India over their patent for the Herceptin breast cancer treatment, they were mistaken. The Indian Health Ministry has moved to revoke the patent even though the Department of Industrial Policy and Promotion rejected a plea for a compulsory license by patient advocates to make the medicine more affordable, The Times of India reports. The move by the Health Ministry, which is taking this step in the public interest, is apparently a highly unusual step that has been taken only twice in the past.
Help employers find you! Check out all the jobs and post your resume.
If Roche execs thought they escaped having a dogfight in India over their patent for the Herceptin breast cancer treatment, they were mistaken. The Indian Health Ministry has moved to revoke the patent even though the Department of Industrial Policy and Promotion rejected a plea for a compulsory license by patient advocates to make the medicine more affordable, The Times of India reports. The move by the Health Ministry, which is taking this step in the public interest, is apparently a highly unusual step that has been taken only twice in the past.
Help employers find you! Check out all the jobs and post your resume.